RECRUITING

A Digital Art Activity to Enhance Self-Disclosure and the Detection of Psycho-social Distress in Adult Cancer Patients

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To look at how a digital art activity may help cancer patients improve their ability to express their distress, symptoms, and lived experience.

Official Title

A Digital Art Activity to Enhance Self-Disclosure and the Detection of Psycho-social Distress in Adult Cancer Patients

Quick Facts

Study Start:2023-11-02
Study Completion:2025-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06127121

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Age equal or greater than 18 years
  2. 2. Patients who are admitted in the hospital and have received a cancer diagnosis.
  3. 3. Suffering from solid cancer or hematological malignancy and receiving active treatment for their cancer.
  4. 4. Voluntary written consent.
  5. 5. Fluent in English or Spanish.
  1. 1. Not being able to use a digital tablet
  2. 2. Being speech impaired or vision impaired
  3. 3. Patients who are cognitively impaired and unable to read or consent for the study
  4. 4. Pregnant women

Contacts and Locations

Study Contact

Carlos Roldan, MD
CONTACT
(713) 563-7402
croldan@mdanderson.org

Principal Investigator

Carlos Roldan, MD
PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center

Study Locations (Sites)

MD Anderson Cancer Center
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

  • Carlos Roldan, MD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-11-02
Study Completion Date2025-08-31

Study Record Updates

Study Start Date2023-11-02
Study Completion Date2025-08-31

Terms related to this study

Additional Relevant MeSH Terms

  • Cancer